Dmg Group, LLC Amgen Inc Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Dmg Group, LLC holds 3,431 shares of AMGN stock, worth $1.01 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

3,431

Previous 3,572 3.95%

Holding current value

$1.01 Million

Previous $1.12 Million 0.99%

% of portfolio

0.91%

Previous 0.96%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $43,622 - $47,570	-141 Reduced 3.95%	3,431 $1.11 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $14,451 - $17,562	-55 Reduced 1.52%	3,572 $1.12 Million
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $63,453 - $76,596	236 Added 6.96%	3,627 $1.03 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $65,459 - $73,845	-256 Reduced 7.02%	3,391 $976,000
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $75,871 - $94,196	347 Added 10.52%	3,647 $980,000
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $43,068 - $50,927	201 Added 6.49%	3,300 $732,000
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $7,676 - $9,356	34 Added 1.11%	3,099 $758,000
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $21,070 - $26,772	92 Added 3.09%	3,065 $802,000
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $19,528 - $22,024	87 Added 3.01%	2,973 $685,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $96,667 - $107,574	419 Added 16.98%	2,886 $705,000
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $79,814 - $88,295	-364 Reduced 12.86%	2,467 $618,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $563,029 - $644,335	2,831 New	2,831 $634,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account